Neurocrine Biosciences, Inc. (NBIX) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $150.82 -3.62%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q2 EPS of ($0.18), in-line with the analyst estimate of ($0.18).
For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
- Shotspotter (SSTI) Misses Q2 EPS by 19c; Offers Guidance
- Globant (GLOB) Misses Q2 EPS by 10c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
